MedTrace Logo

Parenteral Fish Oil in Major Laparoscopic Abdominal Surgery

NCT01819961 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2013-03-28

No results posted yet for this study

Summary

The aim of this study is to assess the effect of postoperative parenteral fish oil on clinical outcome and immune function after major laparoscopic abdominal surgery.

Conditions

  • Gastric Tumor
  • Pancreatic Tumor
  • Liver Tumor

Interventions

DRUG

MCT/LCT and fish oil

DRUG

MCT/LCT

Sponsors & Collaborators

  • Wei Zhou

    lead OTHER

Principal Investigators

  • Yiping Mou, MD · Sir Run Run Shaw Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2013-10-31
Completion
2013-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01819961 on ClinicalTrials.gov